Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy. uri icon

Overview

publication date

  • October 1, 2019

Identity

PubMed Central ID

  • PMC7446362

Scopus Document Identifier

  • 85086269504

Digital Object Identifier (DOI)

  • 10.1200/PO.19.00197

PubMed ID

  • 32923851

Additional Document Info

volume

  • 3